Term ends Sep 27, 2039 · Low confidence
20-year base term ends Sep 27, 2039
Sep 27, 2019
Sep 27, 2039
Feb 6, 2024
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 0 of 3 maintenance fees are paid so far. Confidence: Low. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Sep 27, 2019, when application 16/585,532, the earliest non-provisional in its chain, was filed (this one was filed Aug 29, 2022); a parent in its chain could not be resolved (the next row) | Sep 27, 2039 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,925,832, US 10,933,020, US 11,452,692, US 11,471,413) | resolves to Sep 27, 2039, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Further caveats on record | The record names parents not resolved: 16585532, 16585532, 16585532 | Low confidence overall | Low confidence |
| Computed term end | The steps above, in order | Sep 27, 2039 | Low confidence |
This family
| Application 62/738,333 | Provisional application no patent term | no patent term |
| US 10,933,020 | In force Sep 2039 | Sep 2039 |
| US 10,925,832 | In force Sep 2039 | Sep 2039 |
| US 11,471,413 | In force Sep 2039 | Sep 2039 |
| Application 17/167,714 | Abandoned not computed | not computed |
| US 11,452,692 | In force Sep 2039 | Sep 2039 |
| US 11,890,378 | this patent Sep 2039 | Sep 2039 |
| US 12,558,317 | In force Oct 2039 | Oct 2039 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 15, 2022 Reel 62106, frame 288 | Betancourt, Aimesther | Corealis Pharma | Assignment of Assignor's Interest |
| Dec 15, 2022 Reel 62106, frame 533 | Corealis Pharma | Karuna Therapeutics, Inc. | Assignment of Assignor's Interest |
| Dec 15, 2022 Reel 62106, frame 713 | Pharmadirections, Inc. | Karuna Therapeutics, Inc. | Assignment of Assignor's Interest |
| Dec 15, 2022 Reel 62106, frame 856 | Rehlaender, Bruce | Pharmadirections, Inc. | Assignment of Assignor's Interest |
| Dec 15, 2022 Reel 62107, frame 11 | Thibert, Roch | Corealis Pharma | Assignment of Assignor's Interest |
| Oct 22, 2024 Reel 69205, frame 476 | Karuna Therapeutics, Inc. | Karuna Therapeutics, Inc. | Certificate of Change of Assignee Principal Business Address |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 10,925,832, US 10,933,020, US 11,452,692, US 11,471,413, ends no earlier than this term, so it caps nothing.